Takeda is an API and finished-dose manufacturer based in Germany. It holds 2 valid CEPs across a filed portfolio of 2 molecules. Its filings concentrate with EMA, DMP (NO) and NMRC (NA). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and EMA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 28 November 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Singen, United Arab Emirates | Not on file |
| Oranienburg, United Arab Emirates | Not on file |
| Konstanz, Germany | Not on file |
| ORANIENBURG, Germany | Not on file |
| Oranienburg, Germany | Not on file |
| Velten, Germany | Not on file |
4 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Pantoprazole | EDQM | 1 |
| Succinylcholine | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 39 | 3 |
| DMP (NO) | 31 | None |
| NMRC (NA) | 20 | None |
| EDA (EG) | 13 | None |
| FAMHP (BE) | 12 | None |
| INFARMED (PT) | 12 | None |
| ZLG (DE) | None | 16 |
| ANVISA (Brazil) | None | 7 |
| US FDA | None | 2 |
| FDA (GH) | None | 1 |
Choose your molecules and target markets. Takeda comes back tiered against every other supplier able to file there.
Start for free